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Chlamydia  trachomatis is  a  global  cause  of blinding 
trachoma  and  sexually  transmitted  infections  (STIs).  We 
used comparative genomics of the family Chlamydiaceae 
to  select  conserved  housekeeping  genes  for  C.  tracho-
matis multilocus sequencing, characterizing 19 reference 
and 68 clinical isolates from 6 continental/subcontinental 
regions.  There  were  44  sequence  types  (ST).  Identical 
STs for STI isolates were recovered from different regions, 
whereas STs for trachoma isolates were restricted by con-
tinent. Twenty-nine of 52 alleles had nonuniform distribu-
tions of frequencies across regions (p<0.001). Phylogenetic 
analysis showed 3 disease clusters: invasive lymphogranu-
loma venereum strains, globally prevalent noninvasive STI 
strains (ompA genotypes D/Da, E, and F), and nonpreva-
lent STI strains with a trachoma subcluster. Recombinant 
strains were observed among STI clusters. Single nucle-
otide  polymorphisms  (SNPs)  were  predictive  of  disease 
specificity. Multilocus and SNP typing can now be used to 
detect diverse and emerging C. trachomatis strains for epi-
demiologic and evolutionary studies of trachoma and STI 
populations worldwide.
C
hlamydia trachomatis is spread by close social con-
tact or sexual activity. Worldwide, C. trachomatis is 
the leading preventable cause of blindness and bacterial 
sexually transmitted infections (STIs). Various typing tech-
niques have been developed to better understand the epi-
demiology and pathogenesis of chlamydial diseases. Early 
typing schemes used monoclonal and polyclonal antibodies 
directed against the major outer membrane (MOMP) (1), 
and differentiated the organism into serovars and seroclass-
es: B class (comprising serovars B, Ba, D, Da, E, L2, L2a), 
C class (A, C, H, I, Ia, J, Ja, K, L1, L3), and intermediate 
class (F, G). Sequencing of ompA, which encodes MOMP, 
has refined typing, detecting numerous trachoma (2,3) and 
sexually transmitted (4,5) serovar subtypes.
Seroclasses,  however,  do  not  correlate  with  disease 
phenotypes. For example, A, B, Ba, and C are responsible 
for trachoma, whereas lymphogranuloma venereum (LGV) 
strains, L1-3, are associated with invasive diseases, such as 
suppurative lymphadenitis and hemorrhagic proctitis (6). 
Other typing techniques, such as restriction fragment length 
polymorphism (7), random amplification of polymorphic 
DNA, or pulsed-field gel electrophoresis (PFGE) (8), and 
amplified fragment length polymorphism (9) also correlate 
poorly with disease phenotype, and none have been stan-
dardized across laboratories.
Multilocus sequence typing (MLST) has been used to 
characterize strains and lineages of numerous pathogens 
associated with human diseases that cause serious illness 
and death, including Neisseria meningitidis, Staphylococ-
cus aureus, Vibrio cholerae, and Haemophilus influenzae. 
MLST uses 500–700 bp sequences of internal regions of 
6–8 housekeeping genes, excluding genes suspected to be 
under immune selection (where there is positive selection 
for sequence diversity) and ribosomal RNA genes (which 
are  multicopy  and  too  conserved)  (10).  Advantages  of 
MLST include its precision, allowing simple interlaborato-
ry comparisons, good discrimination between strains, and 
buffering against the distorting effect of recombination on 
genetic relatedness. MLST data are also amenable to vari-
ous population genetic analyses (11,12). Databases for >30 
species are curated at www.mlst.net and pubmlst.org. In 
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parallel with our study, 2 multilocus schemes have recently 
been developed for C. trachomatis. The first violated the 
above premise by including ompA, which is under immune 
selection (13). The second included only laboratory-adapt-
ed and 5 clinical E strains from the Netherlands (14).
In this work, unlike the other C. trachomatis MLST 
schemes,  we  used  complete  genomic  comparisons  of  7 
strains from 4 species within the family Chlamydiaceae to 
identify conserved  candidate housekeeping genes  across 
the genomes. This approach ensures that the chosen loci 
are stable over the course of evolution, and allows for fu-
ture application of a unified MLST scheme for other Chla-
mydiaceae spp. We typed a diverse worldwide collection 
of reference and clinical isolates from trachoma and STI 
populations, correlating genetic variation with geography 
and disease phenotype. We found disease-specific single 
nucleotide polymorphisms (SNPs) and a diversity of new 
strains  including  recombinant  strains  that  occurred  for 
ompA relative to housekeeping loci, following up on our 
recent discovery of this phenomenon at multiple loci in 
Chlamydiaceae genomes (15–17).
Methods
Reference and Clinical Samples
Nineteen  C.  trachomatis  reference  strains  (A/SA-1, 
B/TW-5,  Ba/Apache-2,  C/TW-3,  D/UW-3,  Da/TW-448, 
E/Bour, F/IC-Cal3, G/UW-57, H/UW-4, I/UW-12, Ia/IU-
4168,  J/UW-36,  Ja/UW-92,  K/UW-31,  L1/440,  L2/434, 
L2a/TW-396, and L3/404) and 68 clinical isolates from 6 
geographic  locations  worldwide  (obtained  from  patients 
with trachoma and STIs including proctitis) were analyzed. 
Because de-identified clinical data and samples were used, 
the research was considered institutional review board ex-
empt by Children’s Hospital Oakland Research Institute.
Selection of Housekeeping Genes
We genome-sequenced 7 strains from 4 species of the 
2  genera  of  Chlamydiaceae:  C.  trachomatis  (strains  D/
UW-3/CX [18] and A/Har-13 [19]), Chlamydia muridar-
um (rodent strain MoPn [20]), Chlamydophila pneumoniae 
(human strains AR39 [20]; CWL029 [21], and J138 [21]), 
and Chlamydophila caviae (guinea pig inclusion conjuncti-
vitis strain [22]), the most distantly related species of Chla-
mydiaceae. On the basis of comparative genomics (20) and 
comparisons generated by CGView (23), we identified an 
initial candidate pool of 14 housekeeping genes (Figure 1) 
present in all 7 genomes with an average BLAST score ra-
tio (BSR) (24) >0.5 for orthologs queried against C. caviae 
relative to the BLAST score of each sequence against itself. 
The BSR of >0.5 provides a cutoff to select genes that have 
lower levels of nucleotide sequence divergence in the ge-
nome (i.e., putative housekeeping genes). We then selected 
7 genes (Figure 1) on the basis of i) diverse chromosomal 
regions where a single recombinational exchange would be 
unlikely to co-introduce >1 selected gene; ii) regions where 
several contiguous genes were involved in metabolic or 
key functions; iii) essential metabolic enzymes (e.g., tRNA 
synthases); iv) genes without similarity to human genes; 
and v) no genes under diversifying selection.
ompA and MLST Analyses
DNA was extracted from isolates using Roche High 
Pure Kits (Roche Diagnostics, Pleasanton, CA, USA) and 
ompA  genotyped  as  described  (15,16,25).  DNASTAR 
(Madison, WI, USA) was used to design primers to am-
plify ≈600–700 bp for each gene (Table 1); BLAST (NCBI; 
http://blast.ncbi.nlm.nih.gov/Blast.cgi) was used to ensure 
primer specificity for C. trachomatis genes. MLST PCR was 
carried out in 96-well plates as described (26). Sequenced 
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Figure 1. Comparison of 14 housekeeping genes among genome 
sequences of 4 Chlamydiaceae species and 7 strains. Circle 1, 
genes on forward Chlamydia trachomatis strand, color coded by role 
category; Circle 2, genes on reverse C. trachomatis strand; Circle 
3, multilocus sequence typing (MLST) candidates, C. trachomatis; 
Circle 4, MLST candidates, C. pneumoniae AR39; Circle 5, MLST 
candidates,  C.  caviae  (GPIC);  Circle  6,  MLST  candidates,  C. 
muridarum (MoPn). Colors in circles 3, 4, 5 and 6 are consistent 
for each gene across genomes i.e., “blue” gene in each circle is 
ortholog in that genome for “blue” gene in C. trachomatis. Blue, 
glyA, serine hydroxymethyl-transferase; red, tryptophanyl-tRNA 
synthetase; yellow, mdhC, malate dehydrogenase; green, V-type 
ATPase, subunit A; cyan, pdhA, pyruvate dehydrogenase; black, 
GTP-binding  protein  lepa;  magenta,  transcription  termination 
factor  rho;  brown,  yhbG,  probable  ABC  transporter  ATP-
binding  protein;  orange,  pykF,  pyruvate  kinase;  olive  green, 
conserved hypothetical protein; gray, acetyl-CoA carboxylase beta 
subunit; pink, threonyl-tRNA synthetase; violet, lysS, lysyl-tRNA 
synthetase; light green, leuS, leucyl-tRNA synthetase. Those 
denoted in boldface above were used for C. trachomatis MLST. 
ompA gene location is shown for C. trachomatis (dark green).Chlamydia trachomatis Infections
DNA  (GenBank  accession  nos.  FJ45414–FJ746022)  us-
ing ABI3700 instruments were aligned by using MegAlign 
(DNASTAR). Each unique sequence for a locus was desig-
nated as a unique allele using Sequence Output (www.mlst.
net). Each allelic profile (made up of the string of integers 
corresponding to allele numbers at the 7 loci) was assigned 
as a different strain or clone and given an ST as a clone de-
scriptor. All STs have been deposited in the C. trachomatis 
site at www.mlst.net.
Allelic profiles and concatenated sequences were used 
to determine the relatedness of isolates. Average pairwise 
diversity between isolates was calculated from the 3,714-
bp concatenated sequence of the 7 loci for each isolate 
joined in-frame using MEGA4 (27). Synonymous (dS) and 
nonsynonymous (dN) substitutions were determined using 
MEGA4 for each locus. Allele frequencies per locus and 
geographic region were calculated using SAS software 9.2 
(SAS Institute, Inc., Cary, NC, USA) with the PROC FREQ 
tool supplying the frequency count. We calculated a clas-
sification index (11) on the basis of allele and ST frequency 
between populations of different geographic regions to de-
termine the probability of association of an allele with a 
particular continental/subcontinent region. Statistical sig-
nificance was determined by 10,000 resamplings of allele 
and ST frequency per region.
Strain Clustering and Single Nucleotide  
Polymorphism Analyses
eBURST (www.mlst.net) was used to identify clusters 
of related and singleton STs that were not closely related 
to any other ST (12) and to predict patterns of evolutionary 
descent. MEGA4 (27) was used to construct a tree from 
concatenated  sequences  by  using  minimum  evolution, 
neighbor joining, or unweighted pair group method with 
arithmetic mean, with various substitution models including 
Kimura 2-parameter, Jukes Cantor, and p-distance; 1,000 
bootstrap replicates were used to test support for each node 
in the tree. The short evolutionary distances (<≈0.01) im-
ply that back-substitutions were rare, and as expected, all 
methods gave similar results (data not shown). SplitsTree 
(www.splitstree.org) was used for evolutionary tree con-
struction by decomposition analyses using the distance ma-
trix produced from pairwise comparisons of concatenated 
sequences to determine interconnected networks (28).
A matrix of all SNPs by ST was produced in Excel. 
SAS was used to identify which SNPs were associated with 
an ST using PROC FREQ. Statistical significance was de-
termined by using a classification index as above for the 
probability of association of a SNP with a particular ST. 
Levene’s test (29) was used to determine whether there was 
equal variance across the 87 isolates. A p value of <0.05 
was considered significant.
Results
Discrimination of C. trachomatis by MLST
Figure 1 shows genomic alignments for C. trachoma-
tis (D/UW-3/CX), C. muridarum, C. pneumoniae (AR39), 
and C. caviae. The C. trachomatis (A/Har-13 and D/UW-3/
CX) and C. pneumoniae (AR39, CWL029, and J138) ge-
nome sequences were almost identical within species for 
gene content and could be represented by D/UW-3/CX and 
AR39, respectively.
ompA  genotypes  were  compared  with  STs  resolved 
by MLST. The online Technical Appendix (available from 
www.cdc.gov/EID/content/15/9/1385-Techapp.pdf) shows 
ompA genotype (first letter of strain ID), ST, assigned alleles, 
and clinical characteristics for each isolate. There were 44 
STs (0.51 ST/isolate) for the 87 isolates. Thirty STs were 
represented by a single isolate. In some cases, STI isolates 
from diverse geographic regions shared the same ST. For 
example, ompA genotype E STI isolates (ST39) were found 
in California, USA; Amsterdam, the Netherlands; Ecuador; 
Lisbon, Portugal; and Tanzania. Similarly, LGV genotypes 
(ST1) were identified in San Francisco, California, USA; 
Seattle, Washington, USA; and Amsterdam; 2 clinical L2b 
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Table 1. Primer pairs used for PCR of chlamydiaceae species and strains 
Locus  Region  Primer name  Sequence (5ƍ ĺ 3ƍ)  Length of sequence, bp 
glyA  CT432  FglyA  GAAGACTGTGGCGCTGTTTTATGG  522 
  RglyA  CTTCCTGAGCGATCCCTTCTGAC   
mdhC  CT376  FmdhC  GGAGATGTTTTTGGCCTTGATTGT  519 
  RmdhC  CGATTACTGCACTACCACGACTCT   
pdhA  CT245  FpdhA  CTACAGAAGCCCGAGTTTTT  549 
  RpdhA  CTGTTTGTTGCATGTGGTGATAAG   
yhbG  CT653  FyhbG  TCAAGTCAATGCAGGAGAAAT  504 
  RyhbG  GATAGTGTTGACGTACCATAGGAT   
pykF  CT332  FpykF  ATCTTATCGCTGCTTCGTT  525 
  RpykF  CAGCAATAATAGGGAGATA   
lysS  CT781  FlysS  GAAGGAATCGATAGAACGCATAAT  576 
  RlysS  ATACGCCGCATAACAGGGAAAAAC   
leuS  CT209  FleuS  TCCCTTGGTCGATCTCCTCAC  519 
  RleuS  GGGCATCGCAAAAACGTAAATAGT   RESEARCH
genotypes (ST33) were restricted to Amsterdam. In con-
trast, no trachoma isolates from different continents shared 
the same ST.
ompA genotypes correlated poorly with relatedness be-
tween strains by MLST data (online Technical Appendix). 
Isolates of the same ST had up to 4 different ompA geno-
types. For example, ST19 included ompA genotypes D, H, 
I, and J. For each ompA genotype, 38%–100% belonged to 
different STs. Different STs with the same ompA genotype 
were closely related by MLST (e.g., isolates with C and F 
ompA genotypes); others were not. Isolates of D, E, and Ja 
ompA genotypes differed at as many as 5 MLST loci.
Allele Characteristics and Localization by Geography
Allele characteristics are shown in Table 2. The num-
ber of alleles at each locus varied from 4 to 11. The av-
erage pairwise distance and dS and dN are provided. We 
determined allele frequencies on the basis of continental/
subcontinental regions (Table 3). The majority of alleles 
were observed multiple times. Seventeen were found only 
once, and 28 were unique to a specific region (Table 3). 
The range was from 1 allele at the lysS locus for South 
America to 9 in North America. The highest frequency of a 
unique allele was 84.6% (leuS allele 7) for Asia, which also 
had the highest proportion of unique alleles, 6/17 (35.29%). 
There was a significant nonuniform distribution of alleles 
at each locus by classification index.
Phylogenetic Grouping of STs by Disease  
Phenotypes and Evidence for Recombination
eBURST (11,12) generated 3 clonal complexes (CC) 
(Figure  2):  trachoma  strains,  A,  B,  Ba,  and  C  (CC-A); 
noninvasive STIs with low population prevalence (CC-B); 
and noninvasive, globally prevalent D/Da, E, and F STIs 
(CC-C). The online Technical Appendix shows eBURST 
data,  including  single,  double,  and  triple  locus  variants 
(S/D/TLVs).
Relationships  between  the  isolates  was  further  ex-
plored  by  constructing  a  minimum-evolution  tree  us-
ing MEGA4 (27). These data showed 3 disease clusters   
(Figure 3). Cluster I comprised noninvasive STIs (eBURST 
CC-B) and a trachoma subcluster (eBURST CC-A). Cluster 
II comprised only invasive LGV strains. Cluster III includ-
ed noninvasive prevalent D/Da, E and F STIs (eBURST 
CC-C). E58t strain (ST39; cluster III) was isolated from the 
conjunctiva of a trachoma patient, most likely representing 
autoinoculation from the urogenital tract, because all other 
isolates of this ST were from STIs.
Nine isolates did not localize on the MLST tree with 
strains of the same ompA genotype (Figure 3). Ja41nl and 
Ja47nl, which were expected to cluster with other J and Ja 
isolates in cluster I if the genome sequences were similar, 
were identical by MLST to reference strain F and clini-
cal isolates F8p, F9p, E19e, and E5s in cluster III. Simi-
larly, D83s, which were expected to cluster with other D 
and Da isolates in cluster III, had the same ST as H40nl, 
H18s, I22p, and J44nl in cluster I; D2s were identical to Ia 
and Ia57e in cluster I. Additionally, G16p did not cluster 
with the other G isolates in cluster I. In analyzing loca-
tions of incongruence between clinical D and E isolates in 
cluster I, compared with those in cluster III, the loci that 
differed were glyA, yhbG, and pykF in which allele assign-
ments were identical, in general, to G, H, I, Ia, J, Ja, and 
K strains (online Technical Appendix) in cluster I. These 
were the exact same loci that differed for Ja41nl and Ja47nl 
in cluster III, compared with other J/Ja isolates in cluster I. 
Ja26s differed at glyA, mdhC, and yhbG, whereas G16p dif-
fered at yhbG, lysS, and leuS. Furthermore, the ompA tree   
(Figure 4) was incongruent with the MLST tree. We inter-
pret all 9 isolates to be recombinants.
SplitsTree  decomposition  evaluated  alternative  evo-
lutionary pathways that might indicate recombination be-
tween MLST loci (Figure 5). There was considerable net-
work structure, providing evidence of alternative pathways 
between  strains,  which  may  indicate  that  recombination 
has influenced the evolution of housekeeping genes for the 
C. trachomatis strains.
SNPs Associated with Disease Phenotypes
We identified 61 polymorphic sites among the 7 loci. 
Multiple SNPs were significantly associated with each of 
the 3 clusters and disease groups (Table 4). For example, 
15 SNPs in yhbG and leuS were 100% specific for all LGV 
strains in cluster III. Any 1 of these SNPs could be used to 
identify these strains. SNPs 4, 29, 31, 33, and 34 (together 
or any 1 alone) were specific for the cluster II STIs. For 
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Table 2. Characteristics of alleles for each locus 
Gene locus  No. alleles  Length, bp  No. polymorphic sites  Average pairwise distance  Average dS  Average dN 
glyA 7 522 5 0.003 0.0101 0.0034
mdhC 4 519 3 0.001 0.0112 0.0025
pdhA 7 549 6 0.0003 0.0076 0.0030
yhbG 8 504 21 0.01 0.0670 0.0026
pykF 7 525 7 0.003 0.0105 0.0034
lysS 8 576 9 0.002 0.0093 0.0044
leuS 11 519 10 0.003 0.0104 0.0055
Overall 52 3,714 61 0.003Chlamydia trachomatis Infections
the trachoma subcluster I, unlike for other clusters, only 
SNP 38 was associated with reference strains B and C and 
all clinical trachoma strains; SNPs 54, 55 and 57 together 
(but not any alone) represented all trachoma strains except 
reference strain A. Based on classification indices and Lev-
ene’s test, the null hypothesis of a uniform distribution of 
SNPs was rejected at the respective locus.
Discussion
Accumulating  evidence  for  recombination  among 
Chlamydiaceae in general, and C. trachomatis in particu-
lar, has motivated a typing system that provides buffering 
from the distorting effects of genetic reshuffling that plague 
systems based on a single locus. We therefore developed 
an MLST scheme derived from comparative genomics of 
species  within  the  family  Chlamydiaceae  to  select  con-
served chromosomally dispersed housekeeping genes. Our 
scheme showed considerable variability in allelic profiles 
associated with geographic regions, as well as diverse and 
recombinant strains. We also identified SNPs that correlat-
ed with the 3 C. trachomatis disease groups: invasive LGV 
diseases, noninvasive urogenital diseases, and trachoma.
Comparative  genomics  of  Chlamydia  and  Chlamy-
dophila spp. identified 14 conserved housekeeping genes 
that could be used to extend MLST schemes for these and 
potentially other Chlamydiaceae spp.. Surprisingly, each 
gene was located in a different position within the respec-
tive genome, indicating a lack of synteny among chromo-
somes (20) (Figure 1), except for the 2 C. trachomatis and 
3 C. pneumoniae strains, which share within species >99% 
nucleotide sequence identity. This finding suggests that fu-
ture schemes should select loci to ensure reasonable cover-
age of the chromosome.
Although there was relatively little sequence diversity 
in the housekeeping genes, the number of STs (0.51 ST/iso-
late) was similar to that of other bacterial pathogens. The 
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Table 3. Allele frequencies by geographic region by locus 
Allele frequency, no. (%)* 
Gene
locus
No.
alleles
Africa
(n = 11) 
Northern Europe 
(n = 14) 
Southern Europe 
(n = 10) 
Asia
(n = 13) 
North America  
(n = 33) 
South America
(n = 6) 
Classification 
index
p value 
glyA 7 3 (90.9) 
6 (9.1) 
1 (7.1) 
3 (42.9) 
4 (7.1)
5 (14.3)
6 (28.6) 
3 (60) 
6 (40) 
3 (30.8) 
6 (7.7) 
7 (61.5)
1 (15.1) 
2 (3.0)
3 (54.6) 
6 (27.3) 
3 (33.3) 
6 (66.7) 
<0.001
mdhC 4 3 (90.9) 
4 (9.1) 
1 (7.1) 
2 (14.3)
3 (64.3) 
4 (14.3) 
3 (80) 
4 (20) 
3 (100)  1 (18.2) 
3 (72.7) 
4 (9.1) 
3 (50.0) 
4 (50.0) 
<0.001
pdhA 7 1 (9.1)
3 (90.9) 
2 (7.1)
3 (92.9) 
3 (60) 
4 (30)
7 (10)
3 (100)  3 (94.0) 
5 (3.0)
6 (3.0) 
3 (100.0)  <0.001
yhbG 8 2 (9.1) 
6 (90.9) 
2 (28.6) 
3 (7.1) 
6 (42.7) 
8 (21.4) 
2 (40) 
6 (50) 
7 (10)
1 (7.7)
4 (7.7)
5 (7.7) 
6 (76.9) 
2 (21.2) 
3 (3.0) 
5 (3.0) 
6 (57.6) 
8 (15.2) 
2 (66.7) 
6 (33.3) 
<0.001
pykF 7 3 (81.8) 
6 (9.1) 
7 (8.1) 
1 (12.5) 
6 (50) 
7 (37.5) 
6 (60) 
7 (40) 
3 (92.3) 
7 (7.7) 
1 (18.2) 
2 (9.1)
4 (3.0)
5 (3.0)
6 (39.4) 
7 (27.3) 
6 (33.3) 
7 (66.7) 
<0.001
lysS 8 4 (15.2) 
5 (72.7) 
7 (9.1)
1 (14.3) 
4 (78.6) 
8 (7.1) 
4 (70) 
8 (30) 
4 (7.7) 
5 (30.8) 
6 (61.5) 
1 (3.0) 
3 (3.0)
4 (75.8) 
8 (18.2) 
2 (16.7)
4 (66.7) 
8 (16.7) 
<0.001
leuS 11 2 (9,1) 
3 (9.1) 
9 (81.8) 
3 (57.1) 
6 (21.4)
11(21.4) 
3 (80) 
4 (10)
5 (10)
2 (7.7) 
7 (84.6)
10 (7.7)
1 (3.0)
3 (48.5) 
8 (30.3)
9 (3.0) 
11 (15.2) 
3 (100.0)  <0.001
Total no. 
alleles
52 17 24 17 17 31 13
*Numbers are arranged vertically for each locus to represent the individual alleles (e.g., glyA, alleles are assigned 1, 2, 3, 4, 5, 6 and 7 because there are 
7 alleles for this locus). Alleles marked in boldface are specific for a single geographic region. n values indicate number of samples. RESEARCH
previous C. trachomatis MLST scheme had 0.60 ST/isolate 
(14). None of the loci were identical to ours. In a recent 
study of the bacterium Burkholderia pseudomallei in Aus-
tralia, there were 0.65 ST/isolate (11,12) with relatively lit-
tle diversity and few alleles per locus. However, high levels 
of recombination are believed to shuffle alleles to generate 
different large numbers of allelic profiles (STs). The extent 
to which recombination among alleles generates novel STs 
in C. trachomatis is unclear. Although the number of STs 
per isolate varies, the majority of MLST schemes have been 
successful for strain discrimination, epidemiologic studies, 
and evaluation of organism evolution (10). MLST, howev-
er, may not be sufficiently discriminatory for some epide-
miologic investigations, even with increased loci numbers. 
This may be the case for LGV strains, although our scheme 
resolved 2 L2b strains from all other LGV strains.
We found that a number of STs for STI isolates were 
shared  across  continents.  This  finding  was  particularly 
evident for those from Amsterdam, Ecuador, Lisbon, and 
San Francisco, which would be expected given increasing 
opportunities for global travel and international sexual en-
counters. Notably, L2b isolates (ST33) from proctitis cases 
differed at 2 loci from other LGV isolates (ST1) and were 
restricted to Amsterdam. Although some L2b strains from 
Amsterdam and San Francisco have historically been simi-
lar (30), ST differentiation most likely reflects the emer-
gence of these strains among men who have sex with men. 
Not surprisingly, STs for trachoma isolates were restricted 
to the geographic region of origin where populations travel 
only locally.
Allele frequencies were assigned on the basis of conti-
nental/subcontinental regions (Table 3). Most alleles were 
observed multiple times, and more than half were region 
specific.  Despite  the  opportunity  for  worldwide  spread, 
some strains may be stable within the respective geographic 
populations. This stability was particularly evident in Afri-
ca and Asia, where the frequency of unique alleles was the 
highest, although this finding also reflects the fact that most 
isolates were from trachoma populations. As expected, we 
found, in general, a statistically significant nonuniform dis-
tribution of alleles.
Analyses  using  eBURST  and  trees  constructed  in 
MEGA4 resolved isolates into clonal complexes or clusters. 
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Figure 2. eBURST population snapshot for Chlamydia trachomatis 
isolates.  Sequence  types  (STs)  that  are  linked  differ  at  single 
multilocus sequence typing locus and represent clonal complexes. 
Strains in the same clonal complexes are likely descended from 
the same recent ancestor. Each circle represents a ST. An ST in 
blue is most likely the primary founder of the clonal complex; STs 
in red are subgroup founders. The number of isolates of each ST 
is represented by the area of the circle. Clonal complex A (CC-A) 
for trachoma strains; CC-B, noninvasive, nonprevalent urogenital 
strains;  and  CC-C,  noninvasive,  globally  prevalent  urogenital 
strains.  The  eBURST  report  is  shown  in  the  online  Technical 
Appendix,  available  from  www.cdc.gov/EID/content/15/9/1385-
Techapp.pdf. 
Figure  3.  Minimum  evolution  tree.  The  tree  was  constructed 
using  the  matrix  of  pairwise  differences  between  the  87 
concatenated sequences for the 7 loci using maximum composite 
likelihood  method  for  estimating  genetic  distances.  Numbers 
are  bootstrap  values  (1,000  replicates)  >70%.  Lavender, 
invasive  lymphogranuloma  venereum  (LGV);  gold,  noninvasive, 
nonprevalent  sexually  transmitted  infection  (STI)  strains;  red, 
trachoma strains; blue, noninvasive, highly prevalent STI strains; 
green, putative recombinant stains. Scale bar indicates number of 
substitutions per site.Chlamydia trachomatis Infections
Both methods identified distinctive groupings of strains by 
disease phenotypes. STIs caused by less common strains 
formed an eBURST group (CC-B) but were within Cluster 
I on the tree together with the trachoma Subcluster I, which 
was a separate eBURST group (CC-A). A similar clustering 
pattern to our tree was found by Pannyhoek et al. (14) by 
using 16 reference and 5 clinical E strains, but they did not 
distinguish trachoma reference strain B/TW-5 from the LGV 
group. Our Cluster II included only LGV strains. Cluster III 
contained the noninvasive globally prevalent D/Da, E, and F 
strains (eBURST CC-C). This cluster represents efficiently 
transmitted strains with adaptive fitness in the genital tract.
A number of isolates representing different ompA gen-
otypes shared the same ST, whereas many isolates of the 
same ompA genotype had different STs (online Technical 
Appendix). Furthermore, 9 isolates were found outside the 
expected cluster, suggesting that recombinational replace-
ment at the ompA locus occurs relatively frequently. Accu-
mulating evidence supports frequent recombination among 
Chlamydiaceae. Initial evidence came from observations 
of recombination within ompA (4,31) followed by phyloge-
netic analyses (32), and bioinformatic and statistical analy-
ses for multiple species of the family Chlamydiaceae and 
C. trachomatis strains (15). Recently, we showed intergen-
ic recombination involving ompA and pmpC, pmpE-I, and 
frequent recombination throughout the genome with sig-
nificant hotspots for recombination for recent clinical iso-
lates (16,17). Pannekoek et al. noted incongruence between 
ompA and fumC sequences (14). Most recombination in 
our study involved yhbG, glyA, and pykF (online Appendix 
Table) with incongruence, compared with ompA. Based on 
C. trachomatis recombinants that have been created in vit-
ro, the estimated size of transferred DNA ranged from 123 
kb to 790 kb (33). Although additional recombination sites 
may exist in regions that were not sequenced, any gene in 
our study could be involved in lateral gene exchange with 
a range of 1,191 bp for a single gene (e.g., ompA), 27 kb 
(yhbG to ompA) to at least 248 kb (glyA to yhbG), which is 
consistent with DeMars and Weinfurter (33) and our previ-
ous findings (16,17).
Analysis of the 61 SNPs among the 7 loci showed a 
statistically  significant  association  of  specific  polymor-
phisms with each disease cluster (Table 4). A total of 15 
SNPs singly or together identified the LGV cluster. Simi-
larly, 5 SNPs identified the prevalent Cluster II D/Da, E, 
and F strains. Three clinical D and E strains did not contain 
these SNPs and each appeared to be a recombinant with 
other STI strains. Only 1 SNP (in pykF) identified all tra-
choma strains in Subcluster I. Reference trachoma strains 
A and Ba did not contain this SNP, suggesting that they 
may not represent circulating strains among present-day 
populations.
Other studies have associated SNPs or indels in pmp 
and porB genes with specific disease causing C. trachoma-
tis clades (16,34,35). However, SNPs were not individually 
analyzed for specific disease associations and the target 
genes encode surface exposed proteins likely to be under 
selection  for  epitope  variation  to  avoid  immune  system 
surveillance. A frame-shift mutation in 1 of the tryptophan 
synthase genes, trpA, was associated with trachoma strains 
when compared with all others, although some B and C 
strains lack the entire gene (35). Large deletions in the cy-
totoxin loci have also been identified that differentiate the 
3 disease groups, yet strain B is missing these loci (36). 
The latter study relied on reference strains, which may limit 
the use of these deletions for identifying disease-specific 
groups because clinical isolates may vary in deletion size 
or location. Additionally, tryptophan synthase genes and 
cytotoxin loci are located within the 50-kb plasticity zone 
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Figure 4. Minimum evolution tree for ompA. The tree was constructed 
using the matrix of pairwise differences between the 87 sequences 
by using the maximum composite likelihood method for estimating 
genetic distances. Numbers are bootstrap values (1,000 replicates) 
>70%.  Lavender,  invasive  lymphogranuloma  venereum  (LGV); 
gold, noninvasive, nonprevalent sexually transmitted infection (STI) 
strains; red, trachoma strains; blue, noninvasive, highly prevalent 
STI strains; green, putative recombinant stains. Scale bar indicates 
number of substitutions per site.RESEARCH
of the chromosome, a region known for genetic reshuffling 
(20). The current study differs from those previously men-
tioned in that it used housekeeping genes that are not under 
immune selection or in the plasticity zone. Therefore, the 
SNPs we identified are probably neutral and can be used as 
reliable markers for disease association. Furthermore, SNPs 
were based on reference and clinical isolates of multiples of 
the same strains from 6 geographic regions, representing a 
broad diversity of this species.
Given the high rates of infection among STI (37) and 
trachoma  populations  (38,39),  the  ability  to  distinguish 
LGV  and  noninvasive  urogenital  and  trachoma  strains, 
including  mixed  infections,  would  aid  epidemiologists, 
clinicians, and public healthcare workers worldwide in de-
termining appropriate therapeutic or intervention strategies 
(40). Our multilocus and SNP typing can now be used to 
standardize the way an organism is typed; isolates from di-
verse geographic regions worldwide can be identified and 
compared; and diverse and emerging C. trachomatis strains 
can be detected for epidemiologic and evolutionary studies 
among trachoma and STI populations worldwide. 
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Figure  5.  SplitsTree  obtained  by  using 
concatenated sequences of the 7 loci for 
the  87  isolates.  Cluster  I,  noninvasive, 
nonprevalent  Chlamydia  trachomatis 
strains (gold) with trachoma subcluster I 
(red); cluster II, invasive lymphogranuloma 
venereum  (LGV)  isolates  (purple);  and 
cluster III, noninvasive globally prevalent 
sexually transmitted infection (STI) strains 
(blue).  Isolates  colored  green  represent 
putative  recombinant  strains.  Scale  bar 
indicates number of substitutions per site.
Table 4. SNPs and combinations of SNPs that correlate 100% 
with designated cluster and disease phenotype group* 
Gene locus  SNP no.  Cluster III  Cluster II  Subcluster I†
glyA 1–5 4‡
mdhC 6–8
pdhA 9–14
yhbG 15–35 15§  
20
22–26
30
29‡
31
33
34
pykF 36–42 38¶
lysS 43–51
leuS 52–61 52§
56
61
54
55
57
Total no. SNPs  61 15 5 4
*SNP, single nucleotide polymorphism. Each SNP is 100% specific for 
designated cluster and disease group (e.g., SNP 15 identifies cluster III 
but all 15 SNPs are specific to cluster III). Cluster III comprises all clinical 
and reference lymphogranuloma venereum (LGV) strains; cluster II 
comprises all reference and clinical D, Da, E, F, and recombinant clinical 
Ja strains except recombinant clinical D2s, D43nl, E87e, and reference Ja 
strains; subcluster I comprises all reference and clinical trachoma A, B, Ba 
and C strains except reference strains A and Ba. Disease phenotype 
groups: invasive LGV strains (cluster III); trachoma A, B, Ba and C strains 
(subcluster I); and noninvasive globally prevalent STI D/Da, E, and F 
strains (cluster II). Clinical Ja strains likely acquired a Ja ompA gene by 
recombination. 
†SNPs 54, 55, and 57 together (not independently) are specific for all 
trachoma strains except reference A strain. 
‡p<0.01 for classification index. 
§p<0.001 for classification index. 
¶p = 0.008 for classification index. Chlamydia trachomatis Infections
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